Virus removal membrane and preparation method thereof
By combining graft modified PVDF resin and other raw materials, a high-performance virus removal membrane was prepared, which solved the problems of low filtration efficiency and insufficient virus retention under low energy drive, and achieved efficient and long-lived removal Viral effect.
Patent Information
- Application Number
- CN202410604212.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-15
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-05-15
AI Technical Summary
The existing virus-removing membranes cannot effectively filter liquids under low energy drive, and the pure water flux and virus retention rate are insufficient, which limits its application in the field of biopharmaceuticals.
Using graft modified PVDF resin, polythiophene with hydrophilic groups in side chains, pore-generating agents, polyaminopropyl biguanide and glycidyl ether, a high-performance virus removal film is formed through a specific preparation method, including stirring. , heating, standing defoaming, solidification, cleaning and heat treatment, etc., to form a membrane with high purity water flux and virus retention rate.
It realizes efficient liquid filtering under low energy drive, improves the mechanical and anti-pollution properties of the membrane, extends the service life, and improves the pure water flux and virus retention rate, making it suitable for continuous large-scale production.
Abstract
Description
Technical Field
[0001] The present invention relates to the field of membrane separation technology, in particular to a virus removal membrane and a preparation method thereof. Background Art
[0002] Membrane separation technology refers to a separation technology that uses separation membrane as the core and external pressure, concentration difference, etc. as the driving force. It can separate, concentrate, and purify the components in the feed liquid. Compared with traditional distillation and rectification technologies, it has the advantages of high separation efficiency, safe operation at room temperature, no pollution during the treatment process (no impact on product quality) and high product yield. It is widely used in biopharmaceuticals, medical treatment, seawater desalination, industrial semiconductor preparation and other fields.
[0003] The core of membrane separation technology is the separation membrane. In the field of biopharmaceuticals, in order to ensure the safety and effectiveness of drugs, the separation membrane needs to have the function of removing viruses. Currently, there are few virus-removing membranes on the market, and the only virus-removing membranes on the market are mainly reverse osmosis or nanofiltration membranes. They have very low filtering capacity for biological agents and require electricity and energy to drive. They cannot filter under low energy drive. Therefore, there is a lack of filter membranes on the market that can remove viruses while filtering liquids under low energy drive.
[0004] At present, common membrane materials for virus removal membranes include cellulose, PES and PVDF. PVDF (polyvinylidene fluoride) is a semi-crystalline polymer with good mechanical properties, weather resistance and chemical stability. Therefore, it is one of the membrane materials for mainstream ultrafiltration membranes and microfiltration membranes. Compared with other types of membranes, PVDF membranes have better mechanical properties and higher protein yield. However, the existing PVDF membranes cannot improve pure water flux and virus retention rate at the same time, and defects such as easy pore clogging and high price limit its further application in the field of virus removal membranes.
[0005] In order to solve the above problems, a Chinese invention patent application with an application publication date of 2024.01.02 and application publication number of CN117323847A discloses a method for preparing a gravity-type PVDF ultrafiltration membrane material, which relates to the field of membrane separation technology. The invention adds PVDF powder to an NMP solvent, stirs and heats at the same time to obtain the required PVDF solution, adds a nanomaterial modifier, and uses silica SiO2 nanoparticles, which are surface-modified to enhance their compatibility with PVDF. The nanoparticles are used to improve the performance of the membrane, and then the modified PVDF solution is added to the feeding system of a rotary coater and coated on a substrate to improve the uniformity and consistency of the film. The coated film is then accelerated to dry to remove residual solvent, improve the stability and quality of the film, improve the efficiency of filtering and purifying water quality, remove suspended matter, bacteria, viruses and other harmful substances in water, thereby providing a safe and reliable water source. In addition, the modified PVDF ultrafiltration membrane of the application has significant advantages in energy saving and environmental protection, and has the advantages of lower head requirements, energy saving and environmental protection, and simplified cleaning process. However, the pure water flux and virus retention rate of this membrane material still need to be further improved.
[0006] It can be seen that the art still needs a virus removal membrane with high pure water flux and virus retention rate, sufficient loading capacity, and long service life, and a preparation method thereof. Summary of the invention
[0007] The purpose of the present invention is to overcome the deficiencies of the prior art and to provide a virus removal membrane with high pure water flux and virus retention rate, sufficient loading capacity and long service life and a preparation method thereof.
[0008] To achieve the above-mentioned purpose, the technical solution adopted by the present invention is: a virus removal membrane, comprising the following raw materials in parts by weight: 70-80 parts of grafted modified PVDF resin, 5-8 parts of polythiophene with hydrophilic groups on the side chains, 15-25 parts of porogen, 3-5 parts of polyaminopropyl biguanide, and 4-6 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
[0009] Preferably, the preparation method of the graft modified PVDF resin comprises the following steps: adding the PVDF resin to an alkali solution, stirring at 55-65°C for 15-25 minutes, then washing with deionized water, filtering, and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride to a mixed solvent, stirring and reacting at 68-80°C in an inert gas atmosphere for 9-13 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake and placing it in a Soxhlet extractor, distilling and purifying it with deionized water, and drying the purified product at 62-75°C to constant weight to obtain a graft modified PVDF resin.
[0010] Preferably, the alkali solution is a mixture of KOH, water and anhydrous ethanol in a mass ratio of (1-3):(4-6):5.
[0011] Preferably, the mass ratio of the PVDF resin to the alkali solution is 1:(4-6); the model of the PVDF resin is FR904W, which is provided by Shanghai San Ai Fu New Materials Co., Ltd.
[0012] Preferably, the mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, 1-allyl-3-methylimidazole chloride, and mixed solvent is 3:(0.01-0.03):0.1:(0.1-0.3):0.2:(15-25).
[0013] Preferably, the initiator is azobisisobutyronitrile; the mixed solvent is a mixture of water and anhydrous ethanol in a volume ratio of 1:1; and the inert gas is any one of nitrogen, helium, neon and argon.
[0014] Preferably, there is no special requirement for the source of the polythiophene with hydrophilic groups on the side chains. In one embodiment of the present invention, the polythiophene with hydrophilic groups on the side chains is prepared according to the method of Example 2 of the Chinese invention patent with authorization announcement number CN105860033B.
[0015] Preferably, the porogen is any one of polyvinyl pyrrolidone K-30, polyvinyl pyrrolidone K-17, polyvinyl pyrrolidone K-60, polyethylene glycol 200, and polyethylene glycol 400.
[0016] Another object of the present invention is to provide a method for preparing the virus removal membrane, comprising the following steps:
[0017] Step S1, uniformly dispersing the graft-modified PVDF resin, the polythiophene having a hydrophilic group on the side chain and the porogen in an organic solvent to prepare a casting solution;
[0018] Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 65-75° C., and after the film is formed, it is washed with deionized water and dried naturally to obtain a primary film;
[0019] Step S3, soak the primary membrane in a mixed solution of glycidyl ether and KOH in ethanol for 10-20 hours, take it out and heat treat it at 95-105°C for 5-8 hours, then soak the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 8-12 hours, take it out, continue to heat treat it at 80-90°C for 4-6 hours, and finally wash it with water ultrasonically and dry it in sequence to obtain a virus-removing membrane.
[0020] Preferably, the mass ratio of the graft-modified PVDF resin to the organic solvent in step S1 is 1:(6-10).
[0021] Preferably, the organic solvent is at least one of dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide and N-methylpyrrolidone.
[0022] Preferably, in the ethanol mixed solution of glycidyl ether and KOH in step S3, the mass ratio of glycidyl ether, KOH and ethanol is 1:0.1:(5-8).
[0023] Preferably, the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 8-15%.
[0024] Due to the application of the above technical solution, the present invention has the following beneficial effects:
[0025] (1) The method for preparing the virus removal membrane disclosed in the present invention has simple process, convenient operation and control, high preparation efficiency and finished product qualification rate, low dependence on equipment, suitable for continuous large-scale production, and has high promotion and application value.
[0026] (2) The preparation method of the virus removal membrane disclosed in the present invention comprises the following raw materials in parts by weight: 70-80 parts of grafted modified PVDF resin, 5-8 parts of polythiophene with hydrophilic groups on the side chain, 15-25 parts of porogen, 3-5 parts of polyaminopropyl biguanide, and 4-6 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride. Through the mutual cooperation and joint action of the raw materials, the prepared virus removal membrane has high pure water flux and virus interception rate, sufficient loading capacity, and long service life. The grafted modified PVDF resin and the polythiophene with hydrophilic groups on the side chain are blended as the base material. They both contain hydrophilic structures and have good compatibility. They can combine the advantages of the two, so that the prepared product has good mechanical properties, excellent aging resistance, and long service life; after they are blended into a membrane, they will form a specific pore structure, which can effectively improve the pure water flux and virus interception rate. By co-modifying PVDF resin with N-acryloylmorpholine, N-trihydroxymethyl methacrylamide, and 1-allyl-3-methyl imidazole chloride, amphoteric organic ion salt structure, imidazole salt structure, hydroxyl structure, and amide structure are simultaneously introduced into the PVDF resin structure. These structures can further improve the hydrophilicity of PVDF under the multiple effects of electronic effect, conjugation effect, and steric effect, thereby improving the anti-pollution performance of the product and the virus removal effect; they cooperate with other structures and work together to form a specific pore structure inside the membrane structure, giving the product the advantages of high pure water flux and virus interception rate, sufficient load, and long service life. The process of grafting modification first and then film formation can effectively avoid the influence on PVDF performance during post-treatment, and the defect of clogging the pores of the film-formed product and affecting the pure water flux; the grafting conditions are mild, and no radiation process is required, which is easy to implement and low in energy consumption; the grafted hydroxyl structure can also be used as a reaction site for subsequent surface cross-linking.
[0027] (3) The preparation method of the virus removal membrane disclosed in the present invention first uses glycidyl ether to modify the surface of the primary membrane, so that the epoxy groups on the glycidyl ether can undergo an epoxy ring-opening reaction with the hydroxyl groups in the membrane material, and the unreacted epoxy groups can undergo an epoxy ring-opening reaction with the amino groups on the polyaminopropyl biguanide; an interpenetrating network structure is formed on the membrane surface, further improving the comprehensive performance and performance stability of the membrane; the glycerol ether and aminopropyl biguanide structures introduced thereon can further improve the hydrophilicity of the membrane and the microstructure of the membrane surface, giving the product the advantages of high pure water flux and virus retention rate, sufficient loading capacity, and long service life.
[0028] (4) The preparation method of the virus removal membrane disclosed in the present invention adopts water ultrasonic washing, which can avoid the clogging of the pores formed in the membrane during the surface treatment process to a certain extent, and further improve the pure water flux without affecting the virus retention rate and loading capacity. DETAILED DESCRIPTION
[0029] The following description is used to disclose the present invention so that those skilled in the art can implement the present invention. The preferred embodiments described below are only examples, and those skilled in the art may think of other obvious variations.
[0030] Example 1
[0031] A virus removal membrane is made of the following raw materials in parts by weight: 70 parts of grafted modified PVDF resin, 5 parts of polythiophene with hydrophilic groups on the side chains, 15 parts of porogen, 3 parts of polyaminopropyl biguanide, and 4 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
[0032] The preparation method of the graft modified PVDF resin comprises the following steps: adding PVDF resin to an alkali solution, stirring at 55°C for 15 minutes, then washing with deionized water, filtering, and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride to a mixed solvent, stirring and reacting at 68°C in an inert gas atmosphere for 9 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake and placing it in a Soxhlet extractor, distilling and purifying with deionized water, and drying the purified product at 62°C to constant weight to obtain the graft modified PVDF resin; the alkali solution is a mixture formed by mixing KOH, water, and anhydrous ethanol in a mass ratio of 1:4:5; the mass ratio of the PVDF resin to the alkali solution is 1:4; the model of the PVDF resin is F R904W is provided by Shanghai San Ai Fu New Materials Co., Ltd.; the mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trimethylolmethylacrylamide, 1-allyl-3-methylimidazole chloride and mixed solvent is 3:0.01:0.1:0.1:0.2:15; the initiator is azobisisobutyronitrile; the mixed solvent is a mixture of water and anhydrous ethanol in a volume ratio of 1:1; the inert gas is nitrogen; calculated by weight change and elemental analysis, the grafting rate of PVDF resin is 10.8%, wherein the mass ratio of the structural units introduced by N-acryloylmorpholine, N-trimethylolmethylacrylamide and 1-allyl-3-methylimidazole chloride is 0.98:1:1.97; the grafting rate of PVDF resin = (dry weight of PVDF resin after modification - dry weight of PVDF before modification) / dry weight of PVDF before modification.
[0033] There is no special requirement for the source of the polythiophene with hydrophilic groups on the side chains. In one embodiment of the present invention, the polythiophene with hydrophilic groups on the side chains is prepared according to the method of Example 2 of the Chinese invention patent with authorization announcement number CN105860033B; the porogen is polyvinyl pyrrolidone K-30.
[0034] A method for preparing the virus removal membrane comprises the following steps:
[0035] Step S1, uniformly dispersing the grafted modified PVDF resin, polythiophene having a hydrophilic group on the side chain and a porogen in an organic solvent to prepare a casting solution; the mass ratio of the grafted modified PVDF resin to the organic solvent is 1:6; the organic solvent is dimethyl sulfoxide
[0036] Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 65° C. After the film is formed, it is washed with deionized water and dried naturally to obtain a primary film;
[0037] Step S3, soaking the primary membrane in a mixed solution of glycidyl ether and KOH in ethanol for 10 hours, taking it out and heat treating it at 95°C for 5 hours, then soaking the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 8 hours, taking it out, and continuing to heat treat it at 80°C for 4 hours, and finally washing it with water ultrasonic and drying it in sequence to obtain a virus-removing membrane; the mass ratio of glycidyl ether, KOH and ethanol in the mixed solution of glycidyl ether and KOH in ethanol is 1:0.1:5; the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 8%. After testing, the grafting rate of polyaminopropyl biguanide is 2.8%.
[0038] Example 2
[0039] A virus removal membrane is made of the following raw materials in parts by weight: 73 parts of grafted modified PVDF resin, 6 parts of polythiophene with hydrophilic groups on the side chains, 17 parts of porogen, 3.5 parts of polyaminopropyl biguanide, and 4.5 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
[0040] The preparation method of the graft modified PVDF resin comprises the following steps: adding PVDF resin to an alkali solution, stirring at 57°C for 17 minutes, then washing with deionized water, filtering, and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride to a mixed solvent, stirring and reacting at 72°C in an inert gas atmosphere for 10 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake, placing it in a Soxhlet extractor, distilling and purifying it with deionized water, and drying the purified product at 65°C to a constant weight to obtain the graft modified PVDF resin. The alkali solution is a mixture formed by mixing KOH, water and anhydrous ethanol in a mass ratio of 1.5:4.5:5; the mass ratio of the PVDF resin and the alkali solution is 1:4.5; the model of the PVDF resin is FR904W, which is provided by Shanghai San Ai Fu New Materials Co., Ltd.; the mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, 1-allyl-3-methylimidazole chloride and mixed solvent is 3:0.015:0.1:0.15:0.2:17; the initiator is azobisisobutyronitrile; the mixed solvent is a mixture formed by mixing water and anhydrous ethanol in a volume ratio of 1:1; the inert gas is helium.
[0041] The polythiophene with a hydrophilic group on the side chain is prepared according to the method of Example 2 of the Chinese invention patent with the authorization announcement number CN105860033B; the porogen is polyvinyl pyrrolidone K-17.
[0042] A method for preparing the virus removal membrane comprises the following steps:
[0043] Step S1, uniformly dispersing the graft-modified PVDF resin, the polythiophene having a hydrophilic group on the side chain and the porogen in an organic solvent to prepare a casting solution;
[0044] Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 65-75° C., and after the film is formed, it is washed with deionized water and dried naturally to obtain a primary film;
[0045] Step S3, soak the primary membrane in a mixed solution of ethanol of glycidyl ether and KOH for 13 hours, take it out and heat treat it at 98°C for 6 hours, then soak the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 9 hours, take it out, and continue to heat treat it at 83°C for 4.5 hours, and finally wash it with water ultrasonic and dry it in sequence to obtain a virus-removing membrane.
[0046] The mass ratio of the grafted modified PVDF resin and the organic solvent in step S1 is 1:7; the organic solvent is N,N-dimethylformamide; the mass ratio of glycidyl ether, KOH and ethanol in the ethanol mixed solution of glycidyl ether and KOH in step S3 is 1:0.1:6; the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 10%.
[0047] Example 3
[0048] A virus removal membrane is made of the following raw materials in parts by weight: 75 parts of grafted modified PVDF resin, 6.5 parts of polythiophene with hydrophilic groups on the side chain, 20 parts of porogen, 4 parts of polyaminopropyl biguanide, and 5 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
[0049] The preparation method of the graft-modified PVDF resin comprises the following steps: adding PVDF resin to an alkali solution, stirring at 60°C for 20 minutes, then washing with deionized water, filtering, and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride to a mixed solvent, stirring and reacting at 74°C in an inert gas atmosphere for 11 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake, placing it in a Soxhlet extractor, distilling and purifying it with deionized water, and drying the purified product at 69°C to a constant weight to obtain the graft-modified PVDF resin. VDF resin; the alkali solution is a mixture formed by mixing KOH, water and anhydrous ethanol in a mass ratio of 2:5:5; the mass ratio of the PVDF resin and the alkali solution is 1:5; the model of the PVDF resin is FR904W, which is provided by Shanghai San Ai Fu New Materials Co., Ltd.; the mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, 1-allyl-3-methylimidazole chloride and mixed solvent is 3:0.02:0.1:0.2:0.2:20; the initiator is azobisisobutyronitrile; the mixed solvent is a mixture formed by mixing water and anhydrous ethanol in a volume ratio of 1:1; the inert gas is neon.
[0050] The polythiophene with a hydrophilic group on the side chain is prepared according to the method of Example 2 of the Chinese invention patent with the authorization announcement number CN105860033B; the porogen is polyvinyl pyrrolidone K-60.
[0051] A method for preparing the virus removal membrane comprises the following steps:
[0052] Step S1, uniformly dispersing the graft-modified PVDF resin, the polythiophene having a hydrophilic group on the side chain and the porogen in an organic solvent to prepare a casting solution;
[0053] Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 70° C. After the film is formed, it is washed with deionized water and dried naturally to obtain a primary film;
[0054] Step S3, soak the primary membrane in a mixed solution of ethanol of glycidyl ether and KOH for 15 hours, take it out and heat treat it at 100°C for 6.5 hours, then soak the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 10 hours, take it out, and continue to heat treat it at 85°C for 5 hours, and finally wash it with water ultrasonically and dry it in sequence to obtain a virus-removing membrane.
[0055] The mass ratio of the grafted modified PVDF resin and the organic solvent in step S1 is 1:8; the organic solvent is N,N-dimethylacetamide; the mass ratio of glycidyl ether, KOH and ethanol in the ethanol mixed solution of glycidyl ether and KOH in step S3 is 1:0.1:6.5; the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 11%.
[0056] Example 4
[0057] A virus removal membrane is made of the following raw materials in parts by weight: 78 parts of grafted modified PVDF resin, 7.5 parts of polythiophene with hydrophilic groups on the side chain, 23 parts of porogen, 4.5 parts of polyaminopropyl biguanide, and 5.5 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
[0058] The preparation method of the graft modified PVDF resin comprises the following steps: adding PVDF resin to an alkali solution, stirring at 63°C for 23 minutes, then washing with deionized water, filtering, and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride to a mixed solvent, stirring and reacting at 78°C in an inert gas atmosphere for 12 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake, placing it in a Soxhlet extractor, distilling and purifying it with deionized water, and drying the purified product at 73°C to a constant weight to obtain the graft modified PVDF resin. The alkali solution is a mixture formed by mixing KOH, water and anhydrous ethanol in a mass ratio of 2.5:5.5:5; the mass ratio of the PVDF resin and the alkali solution is 1:5.5; the model of the PVDF resin is FR904W, which is provided by Shanghai San Ai Fu New Materials Co., Ltd.; the mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trimethylolmethylacrylamide, 1-allyl-3-methylimidazole chloride and mixed solvent is 3:0.025:0.1:0.25:0.2:23; the initiator is azobisisobutyronitrile; the mixed solvent is a mixture formed by mixing water and anhydrous ethanol in a volume ratio of 1:1; the inert gas is argon.
[0059] The polythiophene having a hydrophilic group on the side chain is prepared according to the method of Example 2 of the Chinese invention patent with authorization announcement number CN105860033B; the porogen is a mixture of polyvinyl pyrrolidone K-30, polyvinyl pyrrolidone K-17, polyvinyl pyrrolidone K-60, polyethylene glycol 200, and polyethylene glycol 400 in a mass ratio of 1:1:2:3:1.
[0060] A method for preparing the virus removal membrane comprises the following steps:
[0061] Step S1, uniformly dispersing the graft-modified PVDF resin, the polythiophene having a hydrophilic group on the side chain and the porogen in an organic solvent to prepare a casting solution;
[0062] Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 73° C. After the film is formed, it is washed with deionized water and dried naturally to obtain a primary film;
[0063] Step S3, soak the primary membrane in a mixed solution of ethanol of glycidyl ether and KOH for 18 hours, take it out and heat treat it at 103°C for 7.5 hours, then soak the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 11 hours, take it out, and continue to heat treat it at 88°C for 5.5 hours, and finally wash it with water ultrasonic and dry it in sequence to obtain a virus-removing membrane.
[0064] The mass ratio of the graft-modified PVDF resin and the organic solvent in step S1 is 1:9.5; the organic solvent is a mixture of dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone in a mass ratio of 1:2:3:1.
[0065] The mass ratio of glycidyl ether, KOH and ethanol in the ethanol mixed solution of glycidyl ether and KOH in step S3 is 1:0.1:7.5; the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 13%.
[0066] Example 5
[0067] A virus removal membrane is made of the following raw materials in parts by weight: 80 parts of grafted modified PVDF resin, 8 parts of polythiophene with hydrophilic groups on the side chains, 25 parts of porogen, 5 parts of polyaminopropyl biguanide, and 6 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
[0068] The preparation method of the graft-modified PVDF resin comprises the following steps: adding the PVDF resin to an alkali solution, stirring at 65°C for 25 minutes, then washing with deionized water, filtering, and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride to a mixed solvent, stirring and reacting at 80°C in an inert gas atmosphere for 13 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake and placing it in a Soxhlet extractor, distilling and purifying with deionized water, and drying the purified product at 75°C to a constant weight to obtain the graft-modified PVDF resin. VDF resin; the alkali solution is a mixture formed by mixing KOH, water and anhydrous ethanol in a mass ratio of 3:6:5; the mass ratio of the PVDF resin and the alkali solution is 1:6; the model of the PVDF resin is FR904W, which is provided by Shanghai San Ai Fu New Materials Co., Ltd.; the mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, 1-allyl-3-methylimidazole chloride and mixed solvent is 3:0.03:0.1:0.3:0.2:25; the initiator is azobisisobutyronitrile; the mixed solvent is a mixture formed by mixing water and anhydrous ethanol in a volume ratio of 1:1; the inert gas is nitrogen.
[0069] The polythiophene with a hydrophilic group on the side chain is prepared according to the method of Example 2 of the Chinese invention patent with the authorization announcement number CN105860033B; the porogen is polyethylene glycol 400.
[0070] A method for preparing the virus removal membrane comprises the following steps:
[0071] Step S1, uniformly dispersing the graft-modified PVDF resin, the polythiophene having a hydrophilic group on the side chain and the porogen in an organic solvent to prepare a casting solution;
[0072] Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 75°C, and after the film is formed, it is washed with deionized water and dried naturally to obtain a primary film;
[0073] Step S3, soak the primary membrane in a mixed solution of ethanol of glycidyl ether and KOH for 20 hours, take it out and heat treat it at 105°C for 8 hours, then soak the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 12 hours, take it out, and continue to heat treat it at 90°C for 6 hours, and finally wash it with water ultrasonically and dry it in sequence to obtain a virus-removing membrane.
[0074] In step S1, the mass ratio of the graft-modified PVDF resin to the organic solvent is 1:10; the organic solvent is N-methylpyrrolidone.
[0075] The mass ratio of glycidyl ether, KOH and ethanol in the ethanol mixed solution of glycidyl ether and KOH in step S3 is 1:0.1:8; the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 15%.
[0076] Comparative Example 1
[0077] A virus removal membrane and a preparation method thereof, which are basically the same as those in Example 1, except that PVDF-g-PAA is used instead of grafted modified PVDF resin, and the PVDF-g-PAA is prepared according to the method in the following document: Preparation of PVDF-g-PAA copolymer and its modified PVDF membrane, Wang Xiankun, Lv Xianghong, Journal of South China Normal University (Natural Science Edition), 2017, 49(4): 28-33, membrane number M10, grafting rate 9.80%.
[0078] Comparative Example 2
[0079] A virus removal membrane and a preparation method thereof are substantially the same as those in Example 1, except that polyaminopropyl biguanide and glycidyl ether are not added.
[0080] In order to further illustrate the beneficial technical effects of the virus removal membranes involved in the embodiments of the present invention, the virus removal membranes involved in Examples 1-5 and Comparative Examples 1-2 were subjected to relevant performance tests. The film thickness of the test samples was 40 microns. The test results are shown in Table 1. The test method is as follows:
[0081] (1) Water flux: The test was conducted using the Millipore Virusmax test device with a 25 mm stainless steel replaceable membrane filter, with an effective filtration area of 4.1 cm 2 , use ultrapure water at a temperature of 25°C and control the pressure at 0.1MPa for filtration test.
[0082] (2) Loading capacity: Under a pressure of 30 psi, a 0.4 g / L IVIG aqueous solution was used as the test solution, and the end point was when the flux of the virus removal membrane decayed by 75%. At this time, the volume of the test solution that had been processed was recorded as the loading capacity of the virus removal membrane.
[0083] (3) Virus retention test: Use polyclonal antibody IgG as the antibody solution, add 5% MVM murine parvovirus and BVDV bovine viral diarrhea virus to the obtained antibody solution, and stir thoroughly to obtain the antibody solution containing the virus. Use Millipore's Virusmax test device with a 25mm stainless steel membrane filter for testing. The calculation formula is as follows: LRV = log10 (C0 / C F ); Wherein: C0 represents the infection titer of the stock solution containing virus antibodies, C F Indicates the infection titer in the filtrate after using the virus removal membrane. The feed liquid pressure is 30psi during the virus retention experiment.
[0084] It can be seen from the data in Table 1 that the virus removal membranes involved in the embodiments of the present invention have higher water flux and loading capacity and stronger virus retention ability than the comparative products; the combined use of grafted modified PVDF resin, polyaminopropyl biguanide and glycidyl ether is beneficial to improving the above properties.
[0085] Table 1
[0086] project Water flux Loading capacity LRV unit <![CDATA[L / (m 2 ·h)]]> <![CDATA[L / m 2 ]]> — Example 1 153 380 5.5 Example 2 156 387 6.0 Example 3 161 392 6.3 Example 4 163 402 6.7 Example 5 165 408 6.9 Comparative Example 1 129 343 4.0 Comparative Example 2 140 367 4.9
[0087] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with this technology to understand the contents of the present invention and implement them accordingly. They cannot be used to limit the protection scope of the present invention. All equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a virus removal membrane, characterized in that: The steps include: Step S1, uniformly dispersing the graft-modified PVDF resin, the polythiophene having a hydrophilic group on the side chain and the porogen in an organic solvent to prepare a casting solution; Step S2, the casting solution prepared in step S1 is placed in a static state for degassing, and then the film is scraped, and then placed in a deionized water coagulation bath at 65-75° C., and after the film is formed, it is washed with deionized water and dried naturally to obtain a primary film; Step S3, soaking the primary membrane in a mixed solution of glycidyl ether and KOH in ethanol for 10-20 hours, taking it out and heat treating it at 95-105°C for 5-8 hours, then soaking the obtained membrane in an aqueous solution of polyaminopropyl biguanide for 8-12 hours, taking it out, and continuing to heat treat it at 80-90°C for 4-6 hours, and finally washing it with water ultrasonic and drying it in sequence to obtain a virus removal membrane; The virus removal membrane is made of the following raw materials in parts by weight: 70-80 parts of grafted modified PVDF resin, 5-8 parts of polythiophene with hydrophilic groups on the side chains, 15-25 parts of porogen, 3-5 parts of polyaminopropyl biguanide, and 4-6 parts of glycidyl ether; the grafted modified PVDF resin is a PVDF resin co-modified by N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, and 1-allyl-3-methylimidazole chloride.
2. The method for preparing a virus removal membrane according to claim 1, characterized in that: The preparation method of the graft modified PVDF resin comprises the following steps: adding the PVDF resin into an alkali solution, stirring at 55-65°C for 15-25 minutes, then washing with deionized water, filtering and drying to obtain the alkali-treated PVDF resin; then adding the alkali-treated PVDF resin, an initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide and 1-allyl-3-methylimidazole chloride into a mixed solvent, stirring and reacting at 68-80°C in an inert gas atmosphere for 9-13 hours, repeatedly washing the reaction product with deionized water, filtering, collecting the filter cake and placing it in a Soxhlet extractor, distilling and purifying with deionized water, and drying the purified product at 62-75°C to constant weight to obtain the graft modified PVDF resin.
3. The method for preparing a virus removal membrane according to claim 2, characterized in that: The alkali solution is a mixture formed by mixing KOH, water and anhydrous ethanol in a mass ratio of (1-3):(4-6):
5.
4. The method for preparing a virus removal membrane according to claim 2, characterized in that: The mass ratio of the PVDF resin to the alkali solution is 1:(4-6); the model of the PVDF resin is FR904W.
5. The method for preparing a virus removal membrane according to claim 2, characterized in that: The mass ratio of the alkali-treated PVDF resin, initiator, N-acryloylmorpholine, N-trihydroxymethylmethylacrylamide, 1-allyl-3-methylimidazole chloride, and mixed solvent is 3: (0.01-0.03): 0.1: (0.1-0.3): 0.2: (15-25).
6. The method for preparing a virus removal membrane according to claim 2, characterized in that: The initiator is azobisisobutyronitrile; the mixed solvent is a mixture of water and anhydrous ethanol in a volume ratio of 1:1; and the inert gas is any one of nitrogen, helium, neon and argon.
7. The method for preparing a virus removal membrane according to claim 1, characterized in that: The porogen is any one of polyvinyl pyrrolidone K-30, polyvinyl pyrrolidone K-17, polyvinyl pyrrolidone K-60, polyethylene glycol 200, and polyethylene glycol 400.
8. The method for preparing a virus removal membrane according to claim 1, characterized in that: The mass ratio of the grafted modified PVDF resin and the organic solvent in step S1 is 1:(6-10); the organic solvent is at least one of dimethyl sulfoxide, N,N-dimethylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone.
9. The method for preparing a virus removal membrane according to claim 1, characterized in that: The mass ratio of glycidyl ether, KOH and ethanol in the ethanol mixed solution of glycidyl ether and KOH in step S3 is 1:0.1:(5-8); the mass percentage concentration of the aqueous solution of polyaminopropyl biguanide in step S3 is 8-15%.
10. A virus removal membrane prepared by the method for preparing a virus removal membrane according to any one of claims 1 to 9.
